Features December 2013 Issue

Experimental Drug Fails to Show Significant HDL-raising Benefits

A Cleveland Clinic study suggests that the medication simply couldn’t improve upon the benefits statin use and other heart-healthy behaviors.

High-density lipoprotein (HDL) cholesterol is often referred to as “good” cholesterol because it helps move low-density lipoprotein (LDL) cholesterol out of the bloodstream and to the liver, where it can be reprocessed. LDL cholesterol contributes to plaque build-up in arteries, leading to atherosclerosis and a higher risk of heart attack and stroke.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.